BCR and posterior cortical atrophy: In contrast, the analyses of our TMA data subsequently illustrated that low expression of FASN was associated with longer BCR-free survival, as reported by Shurbaji et al. [15] in 1996, which demonstrated FASN's potential prognostic role in PCa progression.